The regenerative medicine market size was valued at US$ 7.3 billion in 2019 and predicted to hit US$ 23.7 billion by 2027 with a CAGR of 16.1% from 2020 to 2027.

Key market Insights:

Stem cell therapy is one of the most revolutionary application of regenerative medicine in the real-world scenario.  Stem cell therapy encourages the repair response of ailing, dysfunctional or wounded tissue by means of stem cells or their by products. It is the next big thing in organ transplantation and makes use of cells in the place of donor organs, that are limited in stock. Scientists cultivate stem cells in a laboratory. These stem cells are operated to specialize into particular cells, such as blood cells, heart muscle or nerve cells. The specific cells can then be implanted into an individual. Stem cells have the capability to build all tissue in the human body, therefore have great possibility for future healing uses in tissue repair and regeneration.

Regenerative Medicine Market Size 2020-2027

Crucial factors accountable for market growth are: